Rankings
▼
Calendar
ELAN Q1 2018 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
$12B
Q1 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$736M
+2.4% YoY
Gross Profit
$327M
44.4% margin
Operating Income
$82M
11.1% margin
Net Income
$73M
9.9% margin
EPS (Diluted)
$0.20
QoQ Revenue Growth
-2.4%
Cash Flow
Operating Cash Flow
$47M
Free Cash Flow
$14M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$7.8B
Cash & Equivalents
-$323M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$736M
$719M
+2.4%
Gross Profit
$327M
$376M
-13.0%
Operating Income
$82M
$63M
+30.2%
Net Income
$73M
-$64M
+213.2%
← FY 2018
All Quarters
Q2 2018 →